Evidence map›Paper›PMID 25649082›Full record

ArticleThe Journal of allergy and clinical immunology2015

Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.

Michiko K Oyoshi, Jacqueline Beaupré, Nicholas Venturelli, Christopher N Lewis, Yoichiro Iwakura, Raif S Geha

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Host-microbial dialogues in atopic dermatitis.International immunology · 2019
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Michiko K OyoshiDivision of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass. Electronic address: michiko.oyoshi@childrens.harvard.edu.
Jacqueline BeaupréDivision of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass.
Nicholas VenturelliDivision of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass.
Christopher N LewisDivision of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass.
Yoichiro IwakuraResearch Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Raif S GehaDivision of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass.
Boston Children's Hospital · USTokyo University of Science · JP

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
Targeted Microbiome Transplant in Atopic DermatitisU19AI117673 · NIAID · NATIONAL JEWISH HEALTH · PI GEHA, RAIF SALIM · 2015 to 2019
$30.6M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
NIAID NIH HHS HHSN272201000020CNIAID NIH HHS HHSN272201000020INIAID NIH HHS N01 AI040030NIAID NIH HHS U01 AI147462NIAID NIH HHS U19 AI117673NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

backgroundEczema vaccinatum is a life-threatening complication of smallpox vaccination in patients with atopic dermatitis (AD) characterized by dissemination of vaccinia virus (VV) in the skin and internal organs. Mutations in the filaggrin (FLG) gene, the most common genetic risk factor for AD, confer a greater risk for eczema herpeticum in patients with AD, suggesting that it impairs the response to cutaneous viral infections.

objectiveWe sought to determine the effects of FLG deficiency on the response of mice to cutaneous VV inoculation.

methodsVV was inoculated by means of scarification of unsensitized skin or skin topically sensitized with ovalbumin in FLG-deficient flaky tail (ft/ft) mice or wild-type (WT) control mice. The sizes of primary and satellite skin lesions were measured, and hematoxylin and eosin staining was performed. VV genome copy numbers and cytokine mRNA levels were measured by using quantitative PCR.

resultsVV inoculation in unsensitized skin of ft/ft mice, independent of the matted hair mutation, resulted in larger primary lesions, more abundant satellite lesions, heavier viral loads in internal organs, greater epidermal thickness, dermal cellular infiltration, and higher local Il17a, Il4, Il13, and Ifng mRNA levels than in WT control mice. VV inoculation at sites of topical ovalbumin application amplified all of these features in ft/ft mice but had no detectable effect in WT control mice. The number of satellite lesions and the viral loads in internal organs after cutaneous VV inoculation were significantly reduced in both unsensitized and topically sensitized ft/ftxIl17a(-/-) mice.

conclusionFLG deficiency predisposes to eczema vaccinatum. This is mediated primarily through production of IL-17A.

Indexed as

Genome, ViralAnimalsDermatitis, AtopicDisease ProgressionFemaleFilaggrin ProteinsGene ExpressionHumansInterferon-gammaInterleukin-13Interleukin-17Interleukin-4Intermediate Filament ProteinsKaposi Varicelliform EruptionMaleMiceFilaggrin ProteinsFLG protein, humanIl17a protein, mouseInterferon-gammaInterleukin-13Interleukin-17Interleukin-4Intermediate Filament ProteinsOvalbuminRNA, MessengerfilaggrinIL-17AVaccinia virus

Identifiers

PMID25649082
PMCPMC4461532
OpenAlexW2065650333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.